MODIFICATION TO SERAQUEST VCA IGM— 510(k) K033780

Name: FDA 510(k) clearance K033780
Creator: U.S. Food and Drug Administration
Published: 2004-01-15

Substantially Equivalent

Quest Intl., Inc.

FDA 510(k) clearance K033780 for MODIFICATION TO SERAQUEST VCA IGM, Substantially Equivalent on 2004-01-15. Applicant: Quest Intl., Inc.. Device class: 1.

Clearance details

Applicant: Quest Intl., Inc.
Product code: Code LJN
Device class: Class 1
Regulation: 21 CFR 866.3235
Advisory panel: Microbiology
Date received: 2003-12-04
Decision date: 2004-01-15
Decision: Substantially Equivalent
Clearance type: Special
Location: North Miami, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LJN

view all

K123021 — BIOPLEX 2200 EBV IGM KIT2012-11-02
K073381 — PLEXUS EBV IGM MULTI-ANALYTE DIAGNOSTICS, MODEL: MP0600M2008-08-04
K042092 — ATHENA MULTI-LYTE EBV VCA IGM TEST SYSTEM2005-04-12
K990977 — SERAQUEST EB VAC IGM1999-10-06
K991459 — COPALIS EBV-M ANTIBODY ASSAY1999-05-14

More clearances from Quest Intl., Inc.

view all

K091260 — SERAQUEST EBV EA-D IGG TEST2009-06-08
K033915 — MODIFICATION TO SERAQUEST EB VCA IGG2004-01-16
K023593 — SERAQUEST ANTI-THYROID PEROXIDASE (TPO)2003-02-06
K023592 — SERAQUEST ANTI-THYROGLOBULIN2003-01-06
K003069 — ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEM2000-11-27

Data sourced from openFDA. This site is unofficial and independent of the FDA.